US President Donald Trump announced deals Thursday with pharmaceutical giants Eli Lilly and Novo Nordisk to lower the prices of some popular weight-loss drugs, in exchange for relief from threatened tariffs. Both companies “have agreed to offer their most popular GLP-1 weight-loss drug,” Trump said at the White House, “at drastic discounts.” “Eli Lilly and […]
The New York Finance is the premier platform for bold innovation, visionary leadership, and next-generation entrepreneurship. Dive into compelling stories of emerging ventures, market game-changers, and influential leaders redefining the business landscape. Stay informed with exclusive rankings, strategic insights, and the key trends shaping the global financial future.
Never miss any important news. Subscribe to our newsletter.
Copyright 2025 - The New York Finance - All rights reserved.
Never miss any important news. Subscribe to our newsletter.
